| __timestamp | Jazz Pharmaceuticals plc | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 406114000 | 1802274 |
| Thursday, January 1, 2015 | 449119000 | 2512761 |
| Friday, January 1, 2016 | 502892000 | 2894488 |
| Sunday, January 1, 2017 | 544156000 | 8096274 |
| Monday, January 1, 2018 | 683530000 | 7985229 |
| Tuesday, January 1, 2019 | 736942000 | 8994597 |
| Wednesday, January 1, 2020 | 854233000 | 29772000 |
| Friday, January 1, 2021 | 1451683000 | 33907000 |
| Saturday, January 1, 2022 | 1416967000 | 26579000 |
| Sunday, January 1, 2023 | 1343105000 | 49868547 |
Cracking the code
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Jazz Pharmaceuticals plc and Verona Pharma plc, two prominent players in the industry, have shown contrasting trends in their SG&A expenses from 2014 to 2023. Jazz Pharmaceuticals has seen a steady increase, peaking in 2021 with expenses nearly 3.5 times higher than in 2014. This growth reflects their aggressive expansion and investment in marketing and administration. In contrast, Verona Pharma's SG&A expenses, while significantly lower, have also grown, with a notable spike in 2023, reaching nearly 28 times their 2014 levels. This surge suggests a strategic shift towards scaling operations. Understanding these trends offers valuable insights into each company's strategic priorities and market positioning.
Who Optimizes SG&A Costs Better? Johnson & Johnson or Jazz Pharmaceuticals plc
Breaking Down SG&A Expenses: Merck & Co., Inc. vs Verona Pharma plc
Sanofi or Jazz Pharmaceuticals plc: Who Manages SG&A Costs Better?
Regeneron Pharmaceuticals, Inc. vs Jazz Pharmaceuticals plc: SG&A Expense Trends
Teva Pharmaceutical Industries Limited and Verona Pharma plc: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Verona Pharma plc
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Jazz Pharmaceuticals plc
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Celldex Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Halozyme Therapeutics, Inc. and Verona Pharma plc
Breaking Down SG&A Expenses: Verona Pharma plc vs Ultragenyx Pharmaceutical Inc.
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.
Selling, General, and Administrative Costs: Verona Pharma plc vs Travere Therapeutics, Inc.